Treatment for Arteriovenous Fistula
This study is evaluating whether a device and procedure can improve the patency of dialysis fistulae.
See full descriptionAbout the trial for Arteriovenous Fistula
Treatment Groups
This trial involves 2 different treatments. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
Eligibility
This trial is for patients born any sex aged 18 and older. You must have received newly diagnosed for Arteriovenous Fistula or one of the other 2 conditions listed above. There are 10 eligibility criteria to participate in this trial as listed below.
Approximate Timelines
Measurement Requirements
This trial is evaluating whether Treatment will improve 2 primary outcomes and 13 secondary outcomes in patients with Arteriovenous Fistula. Measurement will happen over the course of Procedure.
Patient Q & A Section
What are common treatments for arteriovenous fistula?
Most patients develop post-operative wounds or hematomas as a result of a arteriovenous fistula, and patients with poor wound healing should not attempt to create their own fistula. Patients undergoing endovascular treatment of a synthetic arteriovenous fistula and a vein bypass may receive antibiotics and anticoagulants to prevent thrombosis of the graft. Local wound excision can be used to treat venous leg ulcers in patients whose lesions are too large to excise with a scalpel. Stenting of arteries can be used to treat arteriovenous malformations or to treat aortoarterial fistulas.
How many people get arteriovenous fistula a year in the United States?
The prevalence of arteriovenous fistula use in the U.S. is 0.8%, or approximately 1.3 million cases annually. This number is considerably higher than the number of end-stage hemodialysis patients. Furthermore, approximately 740,000 patients currently receiving hemodialysis in the United States (approximately 5% of the total U.S. population) will lose the access they have after 1 year.
Can arteriovenous fistula be cured?
In advanced renal failure there is a high risk of secondary venous thrombosis, which is often permanent. A well-established vascular access system reduces thrombotic complications and can be considered a cure for patients with renal failure.
What are the signs of arteriovenous fistula?
The signs of an arteriovenous fistula include bleeding or purpura at the site of insertion of the cannula. The colour of blood and skin surrounding a fistula may be abnormal. Complications of an arteriovenous fistula may include blood clots. To minimize the risk of blood clots and the risk of infection, heparin therapy may be used. The size of the vessels that supply our organs is essential when discussing the diagnosis of arteriovenous fistula. To obtain this information, blood vessels will usually be examined before treatment is started. An abdominal x-ray may aid in the diagnosis of venous or arterial malformations.
What causes arteriovenous fistula?
It is generally agreed that arteriovenous shunts are the result of abnormal fistula formation where arteries and veins branch and become mixed, and thus form a fistula.
What is arteriovenous fistula?
Data from a recent study the most common complications of AVFs were arterial stenosis and the associated vascular access-related deaths. AVF, though not always mandatory, is still mandatory to ensure a continuous access in diabetic and malnourished patients.
Has treatment proven to be more effective than a placebo?
The current evidence does not support the assumption that adjunctive treatment with the sestamibi scan is more effective than no treatment for inducing an increase in blood supply to the kidneys.
Is treatment typically used in combination with any other treatments?
As for other treatments, different combinations of treatments are utilized in the actual practice of medicine. Treatments used for vascular-related maladies in this study include surgical procedures, and they were utilized in combination: with treatments such as embolization, stenting, angioplasty, and sclerotherapy.
What is the primary cause of arteriovenous fistula?
As a conclusion, the most likely cause of arteriovenous fistula in our city was an infectious and inflammatory process. Patients with high blood glucose levels and heart failure tended to have arteriovenous fistulas, and an increase in the number of fistulas with time was seen.
How does treatment work?
The outcomes for treatment of arteriovenous fistulae vary, as does the time from treatment to first intervention. Treatment is better tolerated and results in a better outcome when it starts promptly and is continued. A better outcome may be achieved in treatment centers or centers using the latest techniques.
Does arteriovenous fistula run in families?
AVFs occur as a result of genetic alterations in a small number of patients in our series. The familial pattern of AVF suggested that AVF are in an inherited state. However, genetic analyses need to be completed to understand the causes of AVF.
What is treatment?
The primary purpose of treatment is to improve blood clotting. For example, anticoagulants and antiplatelets are used to treat patients with venous or arterial thromboembols, and in many patients with atrial fibrillation also. Antiplatelets are also given in patients who are also at risk for arterial thrombosis. Patients who have strokes related to arteriovenous malformations also undergo treatment, usually involving antiplatelet medications.